Home/Filings/4/0001104659-22-028760
4//SEC Filing

Coiante Scott M 4

Accession 0001104659-22-028760

CIK 0001781983other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 5:01 PM ET

Size

4.6 KB

Accession

0001104659-22-028760

Insider Transaction Report

Form 4
Period: 2022-02-25
Coiante Scott M
SVP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-02-25$1.74/sh14,817$25,78276,649 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 32,167 restricted stock units.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother

Related Parties

1
  • filerCIK 0001608536

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:01 PM ET
Size
4.6 KB